Invest in drug discovery with ksilink
  1. Home
  2.  » Investors

Ksilink for investors

Discover most efficient drugs, improving lives of patients and their families is our incitement and motivation. Especially for diseases with high medical need such as Myopathies, Psychiatric disorders, Neurodegeneration and Cancer. Supporting Ksilink by investing into our dedicated Fund allows the intiation of new translational projects and their further development in these fields. Each project involves Europe’s top specialists and platforms from hospitals, universities and the pharmaceutical industry.

Derisking drug development

Addressing fields with high medical needs, Ksilink delivers first-in-class drugs with high chances of success for clinical development and market entry. Our program specific spin-offs start with a strong IPR portfolio, access to patient cohorts and a dedicated team of experts. Investing in one of these spin-offs means significant return on investment through milestone and royalty payment.


Your Benefits when investing into Ksilink or a program-specific Spin-off

  • Make huge profits by reaching markets with high medical needs
  • Improve chances for success in clinical development
  • Enable innovation and next generation medicine
  • Partake in spin-offs with strong leadership and IPR
  • Support your specific area of interest
  • Generate important social and economical value